Literature DB >> 11087200

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.

M Puoti1, M Bonacini, A Spinetti, V Putzolu, S Govindarajan, S Zaltron, M Favret, F Callea, F Gargiulo, F Donato, G Carosi.   

Abstract

A total of 204 patients with liver biopsy-proven hepatitis C virus (HCV) infection, 84 with and 120 without human immunodeficiency virus (HIV) coinfection, were studied, to evaluate variables possibly associated with the stage of liver fibrosis. All patients were injection drugs users, with a mean age of 32 years and an estimated duration of HCV infection of 12 years. Twenty-four patients (11%) had many fibrous septa with (5%) or without (6%) cirrhosis, 56 (27%) had few fibrous septa, and 124 (60%) had no fibrous septa. In all patients, an association was found between CD4 cell counts <500 cells/mm(3)and the presence of many fibrous septa (odds ratio, 3.2; P=.037), independent of HIV infection and other factors. These results suggest that HIV infection-induced CD4 depletion is independently associated with the severity of liver fibrosis in chronic HCV infection.

Entities:  

Mesh:

Year:  2000        PMID: 11087200     DOI: 10.1086/317644

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee.

Authors:  Danielle Rouleau; Claude Fortin; Benoît Trottier; Richard Lalonde; Normand Lapointe; Pierre Côté; Jean-Pierre Routy; Marie-France Matte; Irina Tsarevsky; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

2.  Update on Hepatitis B and C Coinfection in HIV.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

Review 3.  Should antiretroviral therapy be started earlier?

Authors:  Joel E Gallant
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

4.  Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.

Authors:  M G Rumi; F De Filippi; C La Vecchia; M F Donato; S Gallus; E Del Ninno; M Colombo
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 5.  The HCV and HIV coinfected patient: what have we learned about pathophysiology?

Authors:  Andrew H Talal; P Wilfredo Canchis; Ira Jacobson
Journal:  Curr Gastroenterol Rep       Date:  2002-02

6.  Management of Hepatitis C in HIV-infected Patients.

Authors:  Benigno Rodriguez; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

7.  Use of the AST to platelet ratio index in HCV/HIV co-infected patients.

Authors:  A G Singal; L V Thomassen; D R Gretch; M C Shuhart
Journal:  Aliment Pharmacol Ther       Date:  2011-01-05       Impact factor: 8.171

8.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 9.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

Review 10.  The role of viral co-infection in HIV-associated non-AIDS-related cancers.

Authors:  David J Riedel; Lydia S Tang; Anne F Rositch
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.